New Phase 3 Data Show Single Dose of STELARAÂ Ustekinumab Induces Clinical Remission and Response in Adults with Moderate to Severe Ulcerative Colitis

8week induction data from pivotal Phase 3 UNIFI study presented during plenary session at the American College of Gastroenterology ACG Annual Scientific Meeting 2018 The Janssen Pharmaceutical Companies of Johnson & Johns...